v3.26.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Total revenue $ 68,298 $ 70,445 $ 264,510 $ 976,340
Expenses:        
Cost of sales 23,488 21,496 68,429 50,936
Research and development 52,446 98,274 218,611 266,444
Selling, general, and administrative 23,645 31,655 79,087 123,357
Impairment of assets held for sale 0 97,038 0 97,038
Total expenses 99,579 248,463 366,127 537,775
Income (loss) from operations (31,281) (178,018) (101,617) 438,565
Other income (expense):        
Interest expense (5,401) (5,482) (15,991) (16,723)
Loss on debt extinguishment 0 (28,714) 0 (28,714)
Other income, net 7,028 9,178 27,772 31,136
Income (loss) before income tax expense (29,654) (203,036) (89,836) 424,264
Income tax expense (benefit) 1,722 (657) 4,418 1,489
Net income (loss) $ (31,376) $ (202,379) $ (94,254) $ 422,775
Net income (loss) per share:        
Basic (in usd per share) $ (0.19) $ (1.25) $ (0.57) $ 2.61
Diluted (in usd per share) $ (0.19) $ (1.25) $ (0.57) $ 2.53
​Weighted average number of common shares outstanding:        
Basic (in shares) 164,924 162,353 164,264 161,811
Diluted (in shares) 164,924 162,353 164,264 168,195
Product sales        
Revenue:        
Total revenue $ 25,693 $ 13,442 $ 86,747 $ 645,844
Licensing, royalties, and other        
Revenue:        
Total revenue $ 42,605 $ 57,003 $ 177,763 $ 330,496